ACHILLES
TEARS

DISEASE AWARENESS PAGE FOR R3 STEM CELL – ACHILLES TEARS

WHAT IS ACHILLES TEARS?

The Achilles tendon, the largest tendon in the body, joins the calf muscles to the heel bone. This tendon enables one to walk, run and jump. Achilles tendon tears happen when the tendon stretches beyond its capacity. Achilles tendon rupture is characterized by a snapping sound associated with severe pain around the ankle and back of the leg.[1]

Causes: Typical causes of Achilles tendon tear include sudden jumping movements, excessive starting and stopping movements and tripping incidents. Fluoroquinolone antibiotics (e.g. Cipro, Factive, Floxina and Levaquin) are also associated with increased risk of tendinitis and tendon tears.

SEARCH

NEWSLETTER

CONTACT US FOR THERAPY

Here are answers to many of the frequently asked questions we receive.

MANAGEMENT

Magnetic resonance imaging (MRI) is required to understand the nature of an Achilles tendon tear—partial or full tear. A partial tear can recover with a leg cast, brace, or splint, but may require surgery in some cases. For a full tear of the Achilles tendon, surgery is mandatory.

Symptomatic relief of Achilles tendon tear include rest of the foot, ice at the area, elevation of the foot and over-the-counter pain medications (ibuprofen, acetaminophen and naproxen). Recovery may take between 2 – 6 weeks, depending upon the severity of the tear. Individuals who had an Achilles tear once are at greater risk for similar injury in the future.

During surgery, an incision is made to access the muscle and tendon. Usual risks associated with such surgical interventions include the side effects of anesthesia and a lengthy recovery process.

INNOVATIVE THERAPIES

Platelet Rich Plasma (PRP) is obtained by concentrating the patient’s blood sample to obtain a platelet-rich fraction. It has been shown that soft tissue healing happens most efficiently when platelet concentration is greater than 1,000,000/μl, as compared with a normal platelet count of 200,000/μl (average). Several studies have demonstrated the usefulness of PRP solutions in the healing of tendon injuries and Achilles tendinitis. [2] [3] [4]

Unlike reconstructive surgery that may permanently weaken the tendon and associated structures, PRP therapy aims to rebuild and strengthen tissues. Moreover, patients with partial tendon tears may take anti-inflammatory agents and pain medication to control the swelling and pain, but the side effects of these drugs may be too unpleasant to continue medication use. In this regard, Platelet Rich Plasma therapy offers easy intervention measures for effective and lasting repair as well as as the control of painful symptoms.

A small volume of solution (containing the PRP) is injected around the painful ligament, tendon insertions or adjacent joint spaces. The cells secrete factors, such as platelet-derived growth factor (PDGF), transforming growth factor beta (TGF-b), vascular endothelial growth factor (VEGF) and epithelial growth factor (EGF), which promotes natural repair and regeneration.

R3 Stem Cell has achieved Institutional Review Board (IRB) approval for the following study, please read about it here on ClinicalTrials.gov:

SAFETY AND CLINICAL OUTCOMES WITH AMNIOTIC AND UMBILICAL CORD TISSUE THERAPY FOR NUMEROUS MEDICAL CONDITIONS

[1] Baer GS, Keene JS. Tendon injuries of the foot and ankle. In: DeLee JC, Drez D Jr., Miller MD, eds. DeLee and Drez’s Orthopaedic Sports Medicine. 3rd ed. Philadelphia, Pa: Saunders Elsevier;2009:section D.

[2] Vora A, Borg-Stein J, Nguyen RT. Regenerative injection therapy for osteoarthritis: fundamental concepts and evidence-based review. PM R. 2012 May;4(5 Suppl):S104-9.

[3] de Mos M, van der Windt AE, Jahr H, et al. Can platelet-rich plasma enhance tendon repair? A cell culture study. Am J Sports Med. 2008 Jun;36(6):1171-8. Epub 2008 Mar 7.

[4] Monto RR.Platelet rich plasma treatment for chronic Achilles tendinosis. Foot Ankle Int. 2012 May;33(5):379-85.

Brand Ambassador Gallery

The USA stem cell leader offers procedures in

7 Countries including:

UNITED STATES

MEXICO

PHILIPPINES

SOUTH AFRICA

PAKISTAN

INDIA

TURKEY

SUCCESS STORIES

*Outcomes will vary between individuals. No claims are being made with regenerative therapies. The FDA considers stem cell therapy experimental. See our THERAPY COMMITMENT HERE.

Actor Ryan Paevey Receives Stem Cell Therapy at R3 Stem Cell

Regenerative Therapy for Kidney Failure – It Changed My Life!

Journey Lead Singer Arnel Pineda Receives Stem Cell Treatment at R3

R3 STEM CELL MASTER CLASS

Learn everything you need to know about the ever expanding field of regenerative medicine in this 8 part series that includes over four hours of entertaining content!

R3 STEM CELL INTERNATIONAL

R3 Stem Cell International includes 45 clinics in 7 countries. These Centers of Excellence treat all types of conditions with safe, effective protocols by expert stem cell physicians.

FREE STEM CELL CONSULTATION

R3 Stem Cell offers a no cost consultation to see if you or a loved one is a candidate for regenerative cell therapies including cytokines, growth factors, exosomes, and stem cells.

PROVIDER PARTNERSHIP

The R3 Partnership Program offers providers an all-in-one regenerative practice program including marketing, consultations and booked procedures!

FREE WEBINAR: AVOID SURGERY WITH STEM CELL THERAPY

ABOUT US

The information provided by R3 Stem Cell is not a substitute for professional medical advice, diagnosis, or treatment. Individual results may vary and only your medical professional can explain all the risks and potential benefits of any therapy based on your circumstances. R3 Stem Cell does not recommend or endorse any specific tests, products, procedures, opinions, or other information that may be mentioned on this website. Reliance on any information provided by R3 Stem Cell, its employees, others appearing on this website at the invitation of R3 Stem Cell, or other visitors to the website is solely at your own risk. R3 Stem Cell is not responsible for the outcome of your procedure. The FDA considers stem cell therapy experimental at this point.